Teledoc (NYSE:TDOC)

adding on short-sided weakness, Teladoc and Livongo disrupting the massive healthcare market that is long overdue to be disrupted.. should be a bumpy ride but a fun one

In consolidation mode for the next half year as there needs to be clear indications as to stocks value basis versus post pandemic statistics. In plain English, will the finances rise after pandemic threat starts to ease somewhat. Although early indications of this model are encouraging, it will be at least two full quarters before the finances, visits per, large health organizations can guesstimate and clear up the muddy water. My feeling is that these vital stats will indicate perceptively much higher participation and thus a substantially higher rate on initial visits as people get more and more comfortable with virtual visits. I see higher price range in the next 3-6 months ( $215-$285} and growing. Thank you for your time.